Travis Murdoch is the founder of Braveheart Bio. Braveheart Bio has raised $190M in total funding. Latest round: Series A.
Travis Murdoch is the founder of Braveheart Bio, a clinical-stage biotechnology company located in San Francisco, California. The company focuses on developing novel therapeutics for hypertrophic cardiomyopathy and related cardiovascular conditions. It was officially launched in 2024 and secured significant Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library